
NSE: NGLFINE · Healthcare · Pharmaceuticals · Market cap ₹1,926 Cr
· Prev close ₹2,934.30 · Volume 10.70 K · 52W ₹1,271–3,602
Same session as: Analysts/Institutional Investor Meet/Con. Call Updates, filed 12 Nov 2026, 10:50 pm IST
Generated NGL Fine-Chem Limited said the audio recording of its Q2 & H1 FY27 earnings conference call, held on November 12, 2026 at 11:00 AM IST, has been uploaded to…
Shown when the day move is above 5%: the most material filing of this session and the one before.
Current ratio Not in our data
Needs current assets and current liabilities from the latest annual balance sheet filed with the exchange.
100%: all profit arrived as cash
| Year | Operating cash | Net profit | Conversion |
|---|---|---|---|
| FY22 | 14 | 50 | 28% |
| FY23 | 35 | 20 | 175% |
| FY24 | 20 | 41 | 49% |
| FY25 | 36 | 21 | 170% |
| FY26 | 43 | 0 | — |
| FY22–26 | 148 | 132 | 112% |